{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:18:36Z","timestamp":1739942316909,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1124\/dmd.109.030767","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T03:09:35Z","timestamp":1269486575000},"page":"1039-1045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Significant Increase in Phenacetin Oxidation on L382V Substitution in Human Cytochrome P450 1A2"],"prefix":"10.1016","volume":"38","author":[{"given":"Qingbiao","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazyna D.","family":"Szklarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.109.030767_bib1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(94)90363-8","article-title":"Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver","volume":"48","author":"Burke","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.109.030767_bib2","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1016\/S0021-9258(17)39456-5","article-title":"Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism","volume":"260","author":"Distlerath","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.109.030767_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/07391102.2005.10507063","article-title":"Regiospecificity of human cytochrome P450 1A1-mediated oxidations: the role of steric effects","volume":"23","author":"Ericksen","year":"2005","journal-title":"J Biomol Struct Dyn"},{"key":"10.1124\/dmd.109.030767_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-5793(97)01173-3","article-title":"Stoichiometry of 7-ethoxycoumarin metabolism by cytochrome P450 2B1 wild-type and five active-site mutants","volume":"416","author":"Fang","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.109.030767_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/abbi.2001.2732","article-title":"Active site mutations of cytochrome p450cam alter the binding, coupling, and oxidation of the foreign substrates (R)- and (s)-2-ethylhexanol","volume":"398","author":"French","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.109.030767_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/tx00022a001","article-title":"Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes","volume":"4","author":"Guengerich","year":"1991","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.109.030767_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-5793(90)80974-N","article-title":"Hydrogen peroxide production during experimental protein glycation","volume":"268","author":"Jiang","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.109.030767_bib8","doi-asserted-by":"crossref","first-page":"22515","DOI":"10.1016\/S0021-9258(18)54602-0","article-title":"Molecular basis for a functionally unique cytochrome P450IIB1 variant","volume":"266","author":"Kedzie","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.109.030767_bib9","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1021\/bi9731450","article-title":"Probing the active site of cytochrome P450 2B1: metabolism of 7-alkoxycoumarins by the wild type and five site-directed mutants","volume":"37","author":"Kobayashi","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.109.030767_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/03602539409029797","article-title":"Molecular modeling of enzymes and receptors involved in carcinogenesis: QSARs and compact-3D","volume":"26","author":"Lewis","year":"1994","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.109.030767_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/dmd.31.4.412","article-title":"Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382","volume":"31","author":"Liu","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030767_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.abb.2003.12.040","article-title":"The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism","volume":"424","author":"Liu","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.109.030767_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.109.030767_bib14","doi-asserted-by":"crossref","first-page":"8982","DOI":"10.1021\/bi00028a006","article-title":"NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam","volume":"34","author":"Modi","year":"1995","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.109.030767_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-2952(93)90504-P","article-title":"Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse","volume":"46","author":"Nerurkar","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.109.030767_bib16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/mol.107.042861","article-title":"Improvement of cyclophosphamide activation by CYP2B6 mutants: from in silico to ex vivo","volume":"73","author":"Nguyen","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.030767_bib17","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0021-9258(20)82245-5","article-title":"The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.109.030767_bib18","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1021\/bi990142+","article-title":"Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties","volume":"38","author":"Parikh","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.109.030767_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/prot.340110304","article-title":"A 175-psec molecular dynamics simulation of camphor-bound cytochrome P-450cam","volume":"11","author":"Paulsen","year":"1991","journal-title":"Proteins"},{"key":"10.1124\/dmd.109.030767_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00130396","article-title":"Predicting the product specificity and coupling of cytochrome P450cam","volume":"6","author":"Paulsen","year":"1992","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/dmd.109.030767_bib21","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.1074\/jbc.M611692200","article-title":"Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2","volume":"282","author":"Sansen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.109.030767_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.109.030767_bib23","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1124\/dmd.108.022640","article-title":"Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants","volume":"36","author":"Tu","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030767_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s002130050149","article-title":"Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine","volume":"128","author":"von Moltke","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/dmd.109.030767_bib25","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1124\/dmd.30.12.1311","article-title":"Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions","volume":"30","author":"Yuan","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030767_bib26","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.1021\/bi000869u","article-title":"Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants","volume":"39","author":"Yun","year":"2000","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.109.030767_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2174\/138920009789895552","article-title":"Insights into the structure, function, and regulation of human cytochrome P450 1A2","volume":"10","author":"Zhou","year":"2009","journal-title":"Curr Drug Metab"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624023961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624023961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.109.030767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:49:38Z","timestamp":1739897378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624023961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0090955624023961"],"URL":"https:\/\/doi.org\/10.1124\/dmd.109.030767","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant Increase in Phenacetin Oxidation on L382V Substitution in Human Cytochrome P450 1A2","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.109.030767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}